Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin add-on versus glimepiride add-on to metformin in type 2 diabetes mellitus
2011-004286-32Phase 4Completed
- Sponsor
- IKFE
- Start
- Oct 2011
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin, glimepiride, metformin in type 2 diabetes mellitus (T2DM), sponsored by IKFE. Started Oct 2011; status: completed.
02
Drugs
vildagliptinglimepiridemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-004286-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004286-32.